Limbix is a prescription digital therapeutics platform that provides mental health treatment for young people.
Limbix is a prescription digital therapeutic company passionate about creating mental health treatments for adolescents. The Limbix team is uniquely suited to develop prescription digital therapeutics, as its diverse team of clinicians, product designers, researchers, and engineers understand the value of pairing clinical expertise with technological innovation. Their first digital therapeutic, SparkRx by Limbix, is available for licensed healthcare professionals to offer to patients nationwide. For more information about Limbix and SparkRx, please visit limbix.com and SparkRx.com.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 7, 2021 | Series A | $15M | 1 | — | — | Detail |
May 5, 2020 | Series A | $9M | 1 | — | — | Detail |
Nov 1, 2016 | Seed | $3M | 1 | Sequoia Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Gaingels | — | Series A |
Sequoia Capital | — | Series A |